On May 23 2010 GE Healthcare and CardioDx entered into a strategic alliance to advance and co-develop diagnostic technologies to improve the care and management of patients with cardiovascular disease.
Building on the alliance, the GE Healthymagination Fund, a new equity fund that makes investments in highly promising healthcare technology companies, has invested US$5 million in CardioDx as part of a Series D round that the fund is leading. The alliance aligns with GE’s healthymagination initiative, which focuses on reducing cost, increasing access and improving quality in healthcare. This marks the first investment for the Healthymagination Fund. Other financial terms were not disclosed.